Cat. No.: DIA-0231207
Product Information | |
---|---|
CAS No. | 252017-04-2 |
Formula | C19H18ClF3N2O5S |
Molecular Weight | 478.87 |
SMILES | CN(C)C(=O)C1=CC=C(C=C1)[S](=O)(=O)C2=CC(=C(NC(=O)C(C)(O)C(F)(F)F)C=C2)Cl |
Target | PDHK |
Product Description | AZD7545 is a potent PDHK inhibitor with IC50 of 36.8 nM and 6.4 nM for PDHK1 and PDHK2, respectively. It failed to inhibit PDHK4 at higher concentrations(>10 nM), AZD7545 stimulates PDHK4 activity. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.